Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers
Clinical trial NCT01572012 · COMPLETED
Trial details
- NCT number
- NCT01572012
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-11-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.